When the fats in cell membranes are oxidized, they break down into reactive aldehydes. Two of the best known are 4-hydroxy-2-nonenal, usually shortened to HNE, and acrolein[1][2]. Three studies, published between 2007 and 2018, asked whether the GHK tripeptide can neutralize them, and also whether it can scavenge free radicals[1][2][3].
The results are real chemistry and they are worth understanding. They are also test-tube and cell results with the copper-free peptide, run at concentrations the studies do not connect to any living tissue. This page explains what was done and where the evidence stops.
Key Takeaways
- In buffer, GHK reacted with and removed HNE, but was significantly less potent than carnosine, the reference compound[1].
- In buffer, GHK also removed acrolein and formed several reaction products, with up to three acrolein molecules added to one GHK molecule[2].
- In a chemical radical-trapping system, GHK reduced hydroxyl and peroxyl radical signals but not superoxide, and it outperformed carnosine and glutathione against hydroxyl[3].
- The chemistry runs used GHK at 0.1 to 1 mM, and the cell experiment saw an effect at 10 µM or less[1][2][3].
- All three studies used GHK without copper, none measured GHK in tissue, and none involved an animal or a person. We found no animal or human study of GHK lowering HNE or acrolein levels.
Why These Aldehydes Get Studied
HNE is described in the first paper as an electrophilic end product formed when omega-6 polyunsaturated fatty acids decompose, and acrolein in the second as a carbonyl toxin made by lipid peroxidation[1][2]. Electrophilic means they are reactive molecules that attach themselves to proteins and other cell components. That reactivity is why they are called toxic.
The authors link HNE to diabetes, kidney disease, retinopathy and neurodegenerative disease, and acrolein to Alzheimer’s disease, arteriosclerosis, diabetes and kidney disease[1][2]. Those are associations drawn in the papers’ own introductions. They are the reason scientists look for compounds that can trap these aldehydes before they bind to something.
Study One: Trapping HNE in a Test Tube
The 2007 study mixed HNE at 50 µM with GHK at 1 mM in phosphate buffer at pH 7.4, which imitates the acidity of body fluids, and followed how fast the HNE disappeared by liquid chromatography[1]. That is a 20-to-1 excess of peptide. Mass spectrometry and nuclear magnetic resonance then confirmed that GHK and HNE had formed a bonded product, called an adduct[1].
The authors concluded that GHK was an effective HNE quencher but significantly less potent than carnosine, a histidine-containing dipeptide used as the reference[1]. They suggested that removing HNE could contribute to a good outcome in wound healing[1]. That is their interpretation of a buffer experiment, and the study did not test a wound.
Why GHK Is Slower Than Carnosine
The second half of the 2007 paper used computer modeling and NMR to explain the gap. Carnosine, in solution, is extended and held by only one internal hydrogen bond, so it needs about 7 kcal/mol of energy to reach the reaction’s transition state[1]. GHK in solution is quasi-folded, held by four internal hydrogen bonds, three of which must break first, which puts its energy barrier at about 20 kcal/mol[1].
In plain terms, GHK folds in on itself and has to unfold before it can react. The authors also found that the shape of the electron clouds in the transition state favored carnosine[1]. The point is that GHK’s reaction with HNE is real, slower than the benchmark, and explained by structure.
Study Two: Trapping Acrolein
The 2008 study reacted acrolein at 30 µM with GHK at 0.1, 0.25, 0.5 and 1.0 mM, again in pH 7.4 phosphate buffer, and followed acrolein loss by chromatography[2]. After four hours the aldehyde had completely disappeared, according to the abstract, though it does not say whether that applies to every GHK concentration[2].
Mass spectrometry found several products. Acrolein added to GHK sequentially, up to three molecules per peptide, at the amino group on the lysine side chain and at two nitrogen atoms in the histidine ring[2]. Two acrolein molecules on the lysine could then link up and dehydrate to form a ring structure[2].
The authors note that GHK had not previously been shown to quench acrolein, and suggest the result points to a possible medicinal use against carbonyl-linked disease[2]. That suggestion is theirs, and nothing in the abstract tests a disease.
A Trap That Gets Used Up
Both aldehyde studies describe a chemical reaction in which GHK is changed. The peptide bonds covalently to the aldehyde, and up to three acrolein molecules can attach to one GHK[1][2]. This is a stoichiometric trap, meaning each GHK molecule can neutralize only a limited number of aldehyde molecules and is then spent.
That differs from how an antioxidant enzyme works, since an enzyme can process many molecules in turn. The abstracts do not say what becomes of the GHK-aldehyde adducts afterward. Whether they are cleared, whether they are harmless and whether the peptide is available in quantity where aldehydes form are all open questions.
Study Three: Radicals and Cells
The 2018 study had two parts. In human Caco-2 cells, a human intestinal cell line, the authors raised reactive oxygen species with tert-butyl hydroperoxide and measured the signal by flow cytometry. GHK reduced the increase in these species at concentrations of 10 µM or less[3].
In the second part they used electron spin resonance, a method that detects radicals directly in chemical reaction mixtures that generate a specific radical. GHK diminished the signals of hydroxyl and peroxyl radicals but not of the superoxide radical[3]. Its effect on hydroxyl was much stronger than that of carnosine or reduced glutathione, two other antioxidants tested alongside it[3].
It is interesting that GHK beat carnosine here and lost to it against HNE. The two experiments measure different things: radical scavenging in one case and covalent aldehyde capture in the other. Different authors ran them about a decade apart, so the results should not be lined up as a single ranking.
The Concentration Question
The two aldehyde studies used GHK at 1 mM and 0.1 to 1.0 mM against aldehydes at 50 µM and 30 µM[1][2]. The cell experiment saw an effect at 10 µM or less[3]. That is a gap of roughly 10-fold to 100-fold between the chemistry runs and the cell result, and it shows that effects at one scale cannot be assumed at the other.
None of the three abstracts reports how much GHK is present in a particular tissue, or how much of an applied or injected dose would reach it. Without that figure, a millimolar concentration in a buffer cannot be compared with anything in a living body. The site’s article on GHK-Cu and oxidative stress deals with the wider antioxidant evidence.
What These Studies Did Not Test
All three used GHK, not GHK-Cu[1][2][3]. The abstracts do not say whether copper-bound GHK reacts with aldehydes or radicals the same way, and copper itself can take part in oxidation chemistry. The page on GHK without the copper explains why a result for one form is not automatically a result for the other.
No study here used an animal, a skin sample or a person. None measured whether GHK lowered aldehyde-modified proteins in any tissue. The gene-expression research covered in the page on UV and antioxidant genes is a different kind of experiment and should be kept separate from these chemistry results.
We found no animal or human study showing that GHK or GHK-Cu reduces HNE or acrolein levels. That is not proof that nothing exists, but it does mean the claim has not been confirmed in the published literature.
Reading It Fairly
The studies show that GHK can chemically capture HNE and acrolein in a buffer, more slowly than carnosine for HNE, and can reduce hydroxyl and peroxyl radical signals and induced oxidative signals in a cell line[1][2][3]. That is a respectable piece of chemistry and a plausible reason for interest in the peptide.
It does not show that GHK-Cu serum protects skin from lipid peroxidation, that it lowers aldehydes in any person, or that it prevents any disease. A product page that describes GHK-Cu as neutralizing toxic aldehydes is borrowing a buffer result and attaching it to a copper complex and a living tissue, which is two steps further than the research went.
Frequently Asked Questions
Does GHK neutralize toxic aldehydes?
In buffer, yes. Test-tube studies showed GHK reacts with and removes both HNE and acrolein, two aldehydes formed when fats oxidize. No animal or human study showing the same effect on HNE or acrolein was found.
Is GHK better than carnosine at trapping HNE?
No. The 2007 study found GHK was an effective HNE quencher but significantly less potent than carnosine. Computer modeling suggested that GHK’s folded shape makes the reaction harder to start.
What concentrations were used?
The HNE study used 1 mM GHK against 50 micromolar HNE, and the acrolein study used 0.1 to 1.0 mM GHK against 30 micromolar acrolein. The cell experiment saw effects at 10 micromolar or less. None of the studies linked these to concentrations in living tissue.
Does GHK scavenge free radicals?
In a chemical radical-trapping system it reduced hydroxyl and peroxyl radical signals but not superoxide. It was much stronger against hydroxyl than carnosine or glutathione. The same study found GHK reduced induced reactive oxygen species in Caco-2 cells at 10 micromolar or less.
Do these results apply to GHK-Cu serums?
Not directly. All three studies used GHK without copper, and none used skin, an animal or a person. Whether copper-bound GHK reacts the same way was not addressed.
References
- Beretta G, et al. Glycyl-histidyl-lysine (GHK) is a quencher of alpha,beta-4-hydroxy-trans-2-nonenal: a comparison with carnosine. insights into the mechanism of reaction by electrospray ionization mass spectrometry, 1H NMR, and computational techniques. Chemical Research in Toxicology (2007). PMID 17672515
- Beretta G, et al. Acrolein sequestering ability of the endogenous tripeptide glycyl-histidyl-lysine (GHK): characterization of conjugation products by ESI-MSn and theoretical calculations. Journal of Pharmaceutical and Biomedical Analysis (2008). PMID 18378108
- Sakuma S, et al. The peptide glycyl-ʟ-histidyl-ʟ-lysine is an endogenous antioxidant in living organisms, possibly by diminishing hydroxyl and peroxyl radicals. International Journal of Physiology, Pathophysiology and Pharmacology (2018). PMID 30042814
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.